by Sabine Possmann | Dec 16, 2022 | Uncategorized
On 15th December, the SME T-CURX GmbH announced the appointment of Thomas Loeser as the new CFO of the company and the attendance of the JPM 41st Annual Healthcare Conference 2023 in San Francisco from Jan 9-12, 2023.Tom has served for more than 20 years as CFO of...
by Sabine Possmann | Dec 8, 2022 | Uncategorized
Monica Casucci, group leader of the innovative immunotherapies unit at IRCCS Ospedale San Raffaele, was awarded by the European Research Council, to refine her outstanding research work on a novel CAR specific for the CD44v6 antigen and strategies to improve CAR-T...
by Sabine Possmann | Dec 8, 2022 | Uncategorized
This year, the most important scientific price of the BAdW, endowed with 25.000 Euro, was awarded to Michael Hudecek, for his outstanding work on gen-modified CART-T cell therapy for cancer treatment. The Schelling price is awarded bi-annually, for outstanding...
by Sabine Possmann | Apr 4, 2022 | Uncategorized
VJHemOnc’s video series on CART cells interviewing HErmann Einsele During the EBMT-EHA 4th European CAR T-cell Meeting, VJHemOnc interviewed Hermann Einsele, MD, FRCP, University of Würzburg, Würzburg, Germany on CAR-T therapy for multiple myeloma patients and...
by Sabine Possmann | Apr 1, 2022 | Uncategorized
VJHemOnc’s video series on CART cells interviewing Michael Hudecek During the EBMT-EHA 4th European CAR T-cell Meeting, VJHemOnc interviewed Michael Hudecek, MD, University of Würzburg, Würzburg, Germany on several exciting CAR-T topics. Watch the videos below,...